"
Team:Wageningen UR/Lovastatin
From 2013.igem.org
(Difference between revisions)
Karrenbelt (Talk | contribs) |
Karrenbelt (Talk | contribs) |
||
| Line 9: | Line 9: | ||
<ul> | <ul> | ||
<li class="fillfirst"><a href="https://2013.igem.org/Team:Wageningen_UR/Why_Aspergillus_nigem">Why Aspergillus nigem?</a></li> | <li class="fillfirst"><a href="https://2013.igem.org/Team:Wageningen_UR/Why_Aspergillus_nigem">Why Aspergillus nigem?</a></li> | ||
| - | <li class="fill"><a href="https://2013.igem.org/Team:Wageningen_UR/ | + | <li class="fill"><a href="https://2013.igem.org/Team:Wageningen_UR/Secondary_metabolites">Secondary metabolites</a></li> |
<li class="current">Lovastatin</li> | <li class="current">Lovastatin</li> | ||
<li><a href="https://2013.igem.org/Team:Wageningen_UR/ATP_biosensor">ATP Biosensor</a></li> | <li><a href="https://2013.igem.org/Team:Wageningen_UR/ATP_biosensor">ATP Biosensor</a></li> | ||
Revision as of 17:50, 11 September 2013
- Safety introduction
- General safety
- Fungi-related safety
- Biosafety Regulation
- Safety Improvement Suggestions
- Safety of the Application
Lovastatin
Subtitle
paragraph title
subparagraph title
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
